Skip to main content
PMC home page
Gut logoLink to Gut
. 1999 Jul;45(1):117–121. doi: 10.1136/gut.45.1.117

Relation between severity of liver disease and renal oxygen consumption in patients with cirrhosis

A Gadano 1, R Moreau 1, J Heller 1, C Chagneau 1, F Vachiery 1, C Trombino 1, A Elman 1, C Denie 1, D Valla 1, D Lebrec 1
PMCID: PMC1727557  PMID: 10369714

Abstract

BACKGROUND—Worsening cirrhosis may lead to increased renal O2 metabolism caused by activation of neurohumoral antinatriuretic substances.
AIMS—To evaluate the relation between the severity of liver disease, sodium excretion, and neurohumoral antinatriuretic substances on the one hand and renal O2 metabolism on the other in patients with cirrhosis.
METHODS—Renal O2 consumption and haemodynamics as well as plasma concentrations of noradrenaline, renin, and aldosterone were measured. Investigations were performed in 14 patients with Pugh's grade A, 43 with grade B, and 29 with grade C liver disease.
RESULTS—Renal O2 consumption significantly increased with the severity of cirrhosis (grade A, 8.9 (1.6); grade B, 15.5 (1.3); grade C, 18.0 (1.5) ml/min/m2). Plasma concentrations of noradrenaline, renin, and aldosterone significantly increased while mean arterial presssure and systemic vascular resistance significantly decreased with the severity of the disease. A significant inverse correlation was found between renal O2 consumption and sodium excretion. A significant direct correlation was found between plasma levels of noradrenaline and aldosterone on the one hand and renal O2 consumption on the other. Renal blood flow and the glomerular filtration rate did not differ significantly between patients with grade C and grade A or B disease.
CONCLUSIONS—This study shows for the first time that, in patients with cirrhosis, worsening of the disease is associated with an increase in renal O2 consumption. The results suggest that increased renal O2 consumption is due to renal tubular sodium retention caused by increased levels of neurohumoral antinatriuretic substances. This neurohumoral activation is related to cirrhosis induced vasodilation.


Keywords: antinatriuretic hormones; cirrhosis; kidney; haemodynamics; O2 consumption; sodium retention

Full Text

The Full Text of this article is available as a PDF (100.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aperia A., Holtbäck U., Syrén M. L., Svensson L. B., Fryckstedt J., Greengard P. Activation/deactivation of renal Na+,K(+)-ATPase: a final common pathway for regulation of natriuresis. FASEB J. 1994 Apr 1;8(6):436–439. doi: 10.1096/fasebj.8.6.8168694. [DOI] [PubMed] [Google Scholar]
  2. Arroyo V., Bosch J., Mauri M., Viver J., Mas A., Rivera F., Rodes J. Renin, aldosterone and renal haemodynamics in cirrhosis with ascites. Eur J Clin Invest. 1979 Feb;9(1):69–73. doi: 10.1111/j.1365-2362.1979.tb01669.x. [DOI] [PubMed] [Google Scholar]
  3. Arroyo V., Ginès P. Mechanism of sodium retention and ascites formation in cirrhosis. J Hepatol. 1993;17 (Suppl 2):S24–S28. doi: 10.1016/s0168-8278(05)80451-9. [DOI] [PubMed] [Google Scholar]
  4. Bernardi M., Trevisani F., Gasbarrini A., Gasbarrini G. Hepatorenal disorders: role of the renin-angiotensin-aldosterone system. Semin Liver Dis. 1994 Feb;14(1):23–34. doi: 10.1055/s-2007-1007295. [DOI] [PubMed] [Google Scholar]
  5. Bernardi M., Trevisani F., Santini C., Zoli G., Baraldini M., Ligabue A., Gasbarrini G. Plasma norepinephrine, weak neurotransmitters, and renin activity during active tilting in liver cirrhosis: relationship with cardiovascular homeostasis and renal function. Hepatology. 1983 Jan-Feb;3(1):56–64. doi: 10.1002/hep.1840030109. [DOI] [PubMed] [Google Scholar]
  6. Bichet D. G., Van Putten V. J., Schrier R. W. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med. 1982 Dec 16;307(25):1552–1557. doi: 10.1056/NEJM198212163072504. [DOI] [PubMed] [Google Scholar]
  7. Brenard R., Moreau R., Pussard E., Champigneulle B., Gaudin C., Hadengue A., Braillon A., Lebrec D. Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis. J Hepatol. 1992 Mar;14(2-3):347–356. doi: 10.1016/0168-8278(92)90182-o. [DOI] [PubMed] [Google Scholar]
  8. Cogan M. G. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension. 1990 May;15(5):451–458. doi: 10.1161/01.hyp.15.5.451. [DOI] [PubMed] [Google Scholar]
  9. DiBona G. F. Renal neural activity in hepatorenal syndrome. Kidney Int. 1984 May;25(5):841–853. doi: 10.1038/ki.1984.99. [DOI] [PubMed] [Google Scholar]
  10. Gadano A., Moreau R., Vachiery F., Soupison T., Yang S., Cailmail S., Sogni P., Hadengue A., Durand F., Valla D. Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites. J Hepatol. 1997 Jun;26(6):1229–1234. doi: 10.1016/s0168-8278(97)80456-4. [DOI] [PubMed] [Google Scholar]
  11. Garg L. C. Actions of adrenergic and cholinergic drugs on renal tubular cells. Pharmacol Rev. 1992 Mar;44(1):81–102. [PubMed] [Google Scholar]
  12. Gentilini P., La Villa G., Romanelli R. G., Foschi M., Laffi G. Pathogenesis and treatment of ascites in hepatic cirrhosis. Cardiology. 1994;84 (Suppl 2):68–79. doi: 10.1159/000176459. [DOI] [PubMed] [Google Scholar]
  13. Gerbes A. L. The role of atrial natriuretic peptide (ANP) in chronic liver disease. Pharmacol Ther. 1993 Jun;58(3):381–390. doi: 10.1016/0163-7258(93)90028-c. [DOI] [PubMed] [Google Scholar]
  14. Hjemdahl P. Catecholamine measurements by high-performance liquid chromatography. Am J Physiol. 1984 Jul;247(1 Pt 1):E13–E20. doi: 10.1152/ajpendo.1984.247.1.E13. [DOI] [PubMed] [Google Scholar]
  15. Lebrec D., Giuily N., Hadengue A., Vilgrain V., Moreau R., Poynard T., Gadano A., Lassen C., Benhamou J. P., Erlinger S. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. J Hepatol. 1996 Aug;25(2):135–144. doi: 10.1016/s0168-8278(96)80065-1. [DOI] [PubMed] [Google Scholar]
  16. Moore K. The hepatorenal syndrome. Clin Sci (Lond) 1997 May;92(5):433–443. doi: 10.1042/cs0920433. [DOI] [PubMed] [Google Scholar]
  17. Moreau R., Gaudin C., Hadengue A., Braillon A., Roulot D., Bacq Y., Lebrec D. Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failure. Nephron. 1993;65(3):359–363. doi: 10.1159/000187513. [DOI] [PubMed] [Google Scholar]
  18. Moreau R., Lebrec D. Transduction of antinatriuretic signals in renal proximal tubular cells in cirrhosis: introduction to novel approaches to the treatment of sodium retention. J Hepatol. 1998 Jun;28(6):1064–1069. doi: 10.1016/s0168-8278(98)80358-9. [DOI] [PubMed] [Google Scholar]
  19. Moreau R., Lee S. S., Soupison T., Roche-Sicot J., Sicot C. Abnormal tissue oxygenation in patients with cirrhosis and liver failure. J Hepatol. 1988 Aug;7(1):98–105. doi: 10.1016/s0168-8278(88)80512-9. [DOI] [PubMed] [Google Scholar]
  20. Pugh R. N., Murray-Lyon I. M., Dawson J. L., Pietroni M. C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 Aug;60(8):646–649. doi: 10.1002/bjs.1800600817. [DOI] [PubMed] [Google Scholar]
  21. Roulot D., Moreau R., Gaudin C., Bacq Y., Braillon A., Hadengue A., Frohly P., Lebrec D. Long-term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis and ascites. Gastroenterology. 1992 Apr;102(4 Pt 1):1309–1318. [PubMed] [Google Scholar]
  22. Schrier R. W., Arroyo V., Bernardi M., Epstein M., Henriksen J. H., Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988 Sep-Oct;8(5):1151–1157. doi: 10.1002/hep.1840080532. [DOI] [PubMed] [Google Scholar]
  23. Silva P. Renal fuel utilization, energy requirements, and function. Kidney Int Suppl. 1987 Oct;22:S9–14. [PubMed] [Google Scholar]
  24. Thadhani R., Pascual M., Bonventre J. V. Acute renal failure. N Engl J Med. 1996 May 30;334(22):1448–1460. doi: 10.1056/NEJM199605303342207. [DOI] [PubMed] [Google Scholar]
  25. Wilkinson S. P., Smith I. K., Williams R. Changes in plasma renin activity in cirrhosis: a reappraisal based on studies in 67 patients and "low-renin" cirrhosis. Hypertension. 1979 Mar-Apr;1(2):125–129. doi: 10.1161/01.hyp.1.2.125. [DOI] [PubMed] [Google Scholar]
  26. Wong F., Blendis L. Pathophysiology of sodium retention and ascites formation in cirrhosis: role of atrial natriuretic factor. Semin Liver Dis. 1994 Feb;14(1):59–70. doi: 10.1055/s-2007-1007298. [DOI] [PubMed] [Google Scholar]
  27. Wood L. J., Massie D., McLean A. J., Dudley F. J. Renal sodium retention in cirrhosis: tubular site and relation to hepatic dysfunction. Hepatology. 1988 Jul-Aug;8(4):831–836. doi: 10.1002/hep.1840080422. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES